All In Biotech

Free tool

FAERS Monitor: Lumify Preservative Free

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218424 or its brand name (Lumify Preservative Free, Brimonidine Tartrate). Reports on generic versions are filed under their own applications.

Reports

3,486

Serious

1,720

49% of reports

Hospitalization

723

Death reported

189

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • eye pain303
  • eye irritation230
  • drug ineffective205
  • product use issue198
  • fatigue185
  • ocular hyperaemia174
  • headache172
  • vision blurred170
  • dizziness146
  • product dose omission issue127
  • death119
  • off label use116
  • diarrhoea113
  • somnolence107
  • dyspnoea102

Reports by year received

View as table
YearReports
200428
200539
200636
200753
200837
200945
201055
201181
201277
201344
201452
201593
2016109
2017112
2018146
2019159
2020275
2021213
2022245
2023291
2024323
2025425
2026548

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,673 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
eye painSignal30332.629.29,216
eye irritationSignal23024.221.45,086
ocular hyperaemiaSignal17422.219.23,496
vision blurredSignal1707.56.5953
product use issueSignal1986.45.6897
somnolenceSignal1073.22.7162
product dose omission issueSignal1272.62.2126
dizziness1461.81.549
headache1721.71.445
fatigue1851.41.225
dyspnoea1021.10.91
diarrhoea1131.10.90
drug ineffective2050.90.81
death1190.80.74
off label use1160.80.76

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.